Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data

Pigment Cell Research

Volumn 16, Issue 3, 2003, Pages 297-306

  Bauer, Jürgen ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Atypical melanocytic nevi; Atypical mole syndrome; Common melanocytic nevi; Cutaneous melanoma; Risk factors

Indexed keywords

CANCER RISK; CONFERENCE PAPER; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN CELL; LENTIGO; MALIGNANT TRANSFORMATION; MELANOCYTIC NEVUS; MELANOMA; MULTIPLE REGRESSION; RISK FACTOR; SKIN TUMOR; SUN EXPOSURE; TARGET CELL;

DYSPLASTIC NEVUS SYNDROME; ENVIRONMENT; HUMANS; MELANOCYTES; MELANOMA; NEOPLASMS, RADIATION-INDUCED; NEVUS, PIGMENTED; PRECANCEROUS CONDITIONS; RISK FACTORS; SKIN NEOPLASMS; SKIN PIGMENTATION;

EID: 0038578681     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2003.00047.x     Document Type: Conference Paper

References (114)

1. Reimer RR, Clark WHJ, Greene MH, Ainsworth AM, Fraumeni JFJ. Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA 1978;239:744-746
2. Clark WHJ, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol 1978;114:732-738
3. Lynch HT, Frichot BC III, Lynch JF. Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978;15:352-356
4. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984;72:257-266
5. Elwood JM, Williamson C, Stapleton PJ. Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources. Br J Cancer 1986;53:65-74
6. Green A, Bain C, McLennan R, Siskind V. Risk factors for cutaneous melanoma in Queensland. Recent Results Cancer Res 1986;102:76-97
7. Osterlind A, Tucker MA, Hou-Jensen K, Stone BJ, Engholm G, Jensen OM. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer 1988;42:200-206
8. Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JA, Clark J. Benign naevi associated with high risk of melanoma. Lancet 1984;2:168
9. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987;17:459-468
10. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989;2:487-490
11. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser J, Weckbecker R, Panizzon, F. Bahmer. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994;102:695-699
12. Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JA, Clark J, Hole DJ. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) 1986;292:1555-1559.
13. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, Noe MC, Diconstanzo MP, Bonerandi JJ. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990;66:387-395
14. Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS, Clark WH Jr. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 2002;94:3192-3209
15. Carli P, Naldi L, Lovati S, La Vecchia C. The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren. Int J Cancer 2002;101:375-379
16. Gulec A, Seckin D, Saray Y, Sarifakioglu E, Moray G, Colak T. Number of acquired melanocytic nevi in renal transplant recipients as a risk factor for melanoma. Transplant Proc 2002;34:2136
17. Clark WHJ, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984;15:1147-1165
18. Kruger S, Garbe C, Buttner P, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 1992;26:920-926
19. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995;33:1000-1007
20. Dennis LK, White E, Lee JA, Kristal A, McKnight B, Odland P. Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study. Am J Epidemiol 1996;143:248-256
21. Sagebiel RW. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness. J Invest Dermatol 1993;100:322S-325S
22. Weiss J, Bertz J, Jung EG. Malignant melanoma in southern Germany: different predictive value of risk factors for melanoma subtypes. Dermatologica 1991;183:109-113
23. Green A, MacLennan R, Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer 1985;35:297-300
24. Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 1990;19:801-810
25. White E, Kirkpatrick CS, Lee JA. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol 1994;139:857-868
26. Loria D, Matos E. Risk factors for cutaneous melanoma: a case-control study in Argentina. Int J Dermatol 2001;40:108-114
27. Augustsson A, Stierner U, Rosdahl I, Suurkula M. Regional distribution of melanocytic naevi in relation to sun exposure, and site-specific counts predicting total number of naevi. Acta Derm Venereol 1992;72:123-127
28. English JS, Swerdlow AJ, MacKie RM, O'Doherty CJ, Hunter JA, Clark J, Hole DJ. Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol 1988;118:641-644
29. Farinas-Alvarez C, Rodenas JM, Herranz MT, Delgado-Rodriguez M. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body. Br J Dermatol 1999;140:457-462
30. Garbe C, Kruger S, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol 1989;28:517-523
31. Augustsson A, Stierner U, Rosdahl I, Suurkula M. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol 1991;71:518-524
32. Halpern AC, Guerry D, Elder DE, Clark WHJ, Synnestvedt M, Norman S, Ayerle R. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. a case-control study. Arch Dermatol 1991;127:995-999
33. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996;73:1605-1611
34. Grulich AE, Bataille V, Swerdlow AJ, Newton-Bishop JA, Cuzick J, Hersey P, McCarthy WH. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales. Australia Int J Cancer 1996;67:485-491
35. Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, Guerry D 4th, Clark WH Jr. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997;277:1439-1444
36. Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton BJ, McCarthy W, Hersey P, Cuzick J. The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer 1998;77:505-510
37. Rodenas JM, Delgado-Rodriguez M, Farinas-Alvarez C, Herranz MT, Serrano S. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain. Am J Epidemiol 1997;145:1020-1029
38. Rieger E, Soyer HP, Garbe C, Buttner P, Kofler R, Weiss J, Stocker U, Kruger S, Roser M, Weckbecker J. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry. Int J Cancer 1995;62:393-397
39. Bain C, Colditz GA, Willett WC, Stampfer MJ, Green A, Bronstein BR, Mihm MC, Rosner B, Hennekens CH, Speizer FE. Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease. Am J Epidemiol 1988;127:703-712
40. Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, Beagrie M. Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study. Arch Dermatol 1990;126:466-471
41. Weiss J, Garbe C, Bertz J, Biltz H, Burg G, Hennes B, Jung EG, Kreysel HW, Orfanos CE, Petzold D. Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study. Hautarzt 1990;41:309-313
42. Dubin N, Moseson M, Pasternack BS. Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res 1986;102:56-75
43. Youl P, Aitken J, Hayward N, Hogg D, Liu L, Lassam N, Martin N, Green A. Melanoma in adolescents: a case-control study of risk factors in Queensland Australia. Int J Cancer 2002;98:92-98
44. Nordlund JJ, Kirkwood J, Forget BM, Scheibner A, Albert DM, Lerner E, Milton GW. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985;45:1855-1861
45. English DR, Armstrong BK. Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. Br Med J (Clin Res Ed) 1988;296:1285-1288.
46. Carli P, Biggeri A, Giannotti B. Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi. J Am Acad Dermatol 1995;32:734-739
47. Naldi L, Lorenzo IG, Parazzini F, Gallus S, La Vecchia C. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer 2000;88:2703-2710
48. Augustsson A, Stierner U, Suurkula M, Rosdahl I. Prevalence of common and dysplastic naevi in a Swedish population. Br J Dermatol 1991;124:152-156
49. Whiteman DC, Valery P, McWhirter W, Green AC. Risk factors for childhood melanoma in Queensland. Australia Int J Cancer 1997;70:26-31
50. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am J Epidemiol 1995;141:934-942
51. Green A, Siskind V, Hansen ME, Hanson L, Leech P. Melanocytic nevi in schoolchildren in Queensland. J Am Acad Dermatol 1989;20:1054-1060
52. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994;102:700-705
53. Harrison SL, MacLennan R, Speare R, Wronski I. Sun exposure and melanocytic naevi in young Australian children. Lancet 1994;344:1529-1532
54. Luther H, Altmeyer P, Garbe C, Ellwanger U, Jahn S, Hoffmann K, Segerling M. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol 1996;132:1473-1478
55. Darlington S, Siskind V, Green L, Green A. Longitudinal study of melanocytic nevi in adolescents. J Am Acad Dermatol 2002;46:715-722
56. Abadir MC, Marghoob AA, Slade J, Salopek TG, Yadav S, Kopf AW. Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles. J Am Acad Dermatol 1995;33:31-36
57. Gallagher RP, McLean DI. The epidemiology of acquired melanocytic nevi. A brief review. Dermatol Clin 1995;13:595-603
58. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994;30:40-48
59. Fritschi L, McHenry P, Green A, Mackie R, Green L, Siskind V. Naevi in schoolchildren in Scotland and Australia. Br J Dermatol 1994;130:599-603
60. Harrison SL, MacKie RM, MacLennan R. Development of melanocytic nevi in the first three years of life. J Natl Cancer Inst 2000;92:1436-1438
61. McLean DI, Gallagher RP. 'Sunburn' freckles, cafe-au-lait macules, and other pigmented lesions of schoolchildren: the Vancouver Mole Study. J Am Acad Dermatol 1995;32:565-570
62. Bataille V, Sasieni P, Cuzick J, Hungerford JL, Swerdlow A, Bishop JA. Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer 1995;60:622-626
63. Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, Beagrie M. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol 1990;126:770-776
64. Breitbart M, Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Breitbart EW, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Hotzmann I, Orfanos CE. Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma, a case-control study of the German Central Malignant Melanoma Registry. Acta Derm Venereol 1997;77:374-378
65. Ballone E, Passamonti M, Lappa G, Di Blasio G, Fazii P. Pigmentary traits, nevi and skin phototypes in a youth population of Central Italy. Eur J Epidemiol 1999;15:189-195
66. Williams ML, Pennella R. Melanoma, melanocytic nevi, and other melanoma risk factors in children. J Pediatr 1994;124:833-845
67. Easton DF, Cox GM, Macdonald AM, Ponder BA. Genetic susceptibility to naevi - a twin study. Br J Cancer 1991;64:1164-1167
68. Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH. Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst 1991;83:1726-1733
69. Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst 2000;92:457-463
70. Briollais L, Chompret A, Guilloud-Bataille M, Bressac-de PB, Avril MF, Demenais F. Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure. Int J Epidemiol 2000;29:408-415
71. Green A, Smith P, McWhirter W, O'Regan P, Battistutta D, Yarker ME, Lape K. Melanocytic naevi and melanoma in survivors of childhood cancer. Br J Cancer 1993;67:1053-1057
72. Smith CH, McGregor JM, Barker JN, Morris RW, Rigden SP, MacDonald DM. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993;28:51-55
73. Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood. Cancer 2003;97:628-638
74. Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984;73:75-82
75. Elwood JM, Gallagher RP, Hill GB, Pearson JC. Cutaneous melanoma in relation to intermittent and constant sun exposure - the Western Canada Melanoma Study. Int J Cancer 1985;35:427-433
76. Gallagher RP, Elwood JM, Yang CP. Is chronic sunlight exposure important in accounting for increases in melanoma incidence? Int J Cancer 1989;44:813-815
77. Coombs BD, Sharples KJ, Cooke KR, Skegg DC, Elwood JM. Variation and covariates of the number of benign nevi in adolescents. Am J Epidemiol 1992;136:344-355
78. Pope DJ, Sorahan T, Marsden JR, Ball PM, Grimley RP, Peck IM. Benign pigmented nevi in children. Prevalence and associated factors: the West Midlands, United Kingdom Mole Study. Arch Dermatol 1992;128:1201-1206
79. English DR, Armstrong BK. Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. Am J Epidemiol 1994;139:390-401
80. Fusaro RM. Multiple interpretations of cancer risks from body mole counts in preventive care. Arch Dermatol 2001;137:823
81. Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M, Grossman L. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 2002;94:94-101
82. Garbe C, Orfanos CE. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res 1992;Suppl. 2:285-294
83. Karrer S, Szeimies RM, Stolz W, Landthaler M. Eruptive melanozytare Navi nach Chemotherapie. Klin Padiatr 1998;210:43-46
84. Steinitz R, Parkin DM, Young JL, Bieber CA, Katz L. Cancer Incidence in Jewish Migrants to Israel, 1961-1981. Lyon, France: IARC Science Publishers 1989; 1-311.
85. Khlat M, Vail A, Parkin M, Green A. Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay. Am J Epidemiol 1992;135:1103-1113
86. Autier P, Dore JF, Cattaruzza MS, Renard F, Luther H, Gentiloni-Silverj F, Zantedeschi E, Mezzetti M, Monjaud I, Andry M, Osborn JF, Grivegnee AR. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Natl Cancer Inst 1998;90:1873-1880
87. Autier P, Dore JF, Negrier S, Lienard D, Panizzon R, Lejeune FJ, Guggisberg D, Eggermont AM. Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst 1999;91:1304-1309
88. Autier P, Dore JF, Reis AC, Grivegnee A, Ollivaud L, Truchetet F, Chamoun E, Rotmensz N, Severi G, Cesarini JP. Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimeters. Br J Cancer 2000;83:1243-1248
89. Hughes BR, Cunliffe WJ, Bailey CC. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ 1989;299:88-91
90. Kraemer KH, Greene MH, Tarone R, Elder DE, Clark WHJ, Guerry D. Dysplastic naevi and cutaneous melanoma risk. Lancet 1983;2:1076-1077
91. Kopf AW, Friedman RJ, Rigel DS. Atypical mole syndrome. J Am Acad Dermatol 1990;22:117-118
92. Newton JA, Bataille V, Griffiths K, Squire JM, Sasieni P, Cuzick J, Bishop DT, Swerdlow A. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? J Am Acad Dermatol 1993;29:989-996
93. Kraemer KH, Tucker M, Tarone R, Elder DE, Clark WHJ. Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med 1986;315:1615-1616
94. Kelly JW, Crutcher WA, Sagebiel RW. Clinical diagnosis of dysplastic melanocytic nevi. a clinicopathologic correlation. J Am Acad Dermatol 1986;14:1044-1052
95. Curley RK, Cook MG, Fallowfield ME, Marsden RA. Accuracy in clinically evaluating pigmented lesions. BMJ 1989;299:16-18
96. Black WC, Hunt WC. Histologic correlations with the clinical diagnosis of dysplastic nevus. Am J Surg Pathol 1990;14:44-52
97. Annessi G, Cattaruzza MS, Abeni D, Baliva G, Laurenza M, Macchini V, Melchi F, Ruatti P, Puddu P, Faraggiana T. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol 2001;45:77-85
98. Ackerman AB. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology 1988;13:241-256
99. Toussaint S, Kamino H. Dysplastic changes in different types of melanocytic nevi. A unifying concept. J Cutan Pathol 1999;26:84-90
100. Roush GC, Nordlund JJ, Forget B, Gruber SB, Kirkwood JM. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med 1988;17:273-279
101. Tiersten AD, Grin CM, Kopf AW, Gottlieb GJ, Bart RS, Rigel DS, Friedman RJ, Levenstein MJ. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome. J Dermatol Surg Oncol 1991;17:44-48
102. Marghoob AA, Kopf AW, Rigel DS, Bart RS, Friedman RJ, Yadav S, Abadir M, Sanfilippo L, Silverman MK, Vossaert KA. Risk of cutaneous malignant melanoma in patients with 'classic' atypicalmole syndrome. a case-control study. Arch Dermatol 1994;130:993-998
103. Marghoob AA, Slade J, Kopf AW, Salopek TG, Rigel DS, Bart RS. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study. Br J Dermatol 1996;135:704-711
104. Greene MH, Clark WHJ, Tucker MA, Kraemer KH, Elder DE, Fraser MC. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 1985;102:458-465
105. Carey WP, Thompson CJ, Synnestvedt M, Guerry D, Halpern A, Schultz D, Elder DE. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 1994;74:3118-3125
106. Novakovic B, Clark WHJ, Fears TR, Fraser MC, Tucker MA. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol 1995;33:631-636
107. Gallagher RP, Elwood JM, Hill GB. Risk factors for cutaneous malignant melanoma: the Western Canada Melanoma Study. Recent Results Cancer Res 1986;102:38-55
108. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JC. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 1987;78:37-44
109. Evans RD, Kopf AW, Lew RA, Rigel DS, Bart RS, Friedman RJ, Rivers JK. Risk factors for the development of malignant melanoma - I. Review of case-control studies. J Dermatol Surg Oncol 1988;14:393-408
110. Elwood JM. Melanoma and sun exposure. Semin Oncol 1996;23:650-666
111. Satyamoorthy K, Herlyn M. Cellular and molecular biology of human melanoma. Cancer Biol Ther 2002;1:14-17
112. MacKie RM, McHenry P, Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 1993;341:1618-1620
113. Elwood JM. Screening for melanoma and options for its evaluation. J Med Screen 1994;1:22-38
114. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001;14:280-290